Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors
- 7 May 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 38 (3) , 177-192
- https://doi.org/10.1016/s1040-8428(01)00103-2
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigenJournal of Clinical Investigation, 2000
- An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyNature Biotechnology, 1998
- Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsGene Therapy, 1998
- Towards efficient cell targeting by recombinant retrovirusesMolecular Medicine Today, 1997
- The use of herpes simplex virus-based vectors for gene delivery to the nervous systemMolecular Medicine Today, 1997
- Retroviral Display of Antibody Fragments; Interdomain Spacing Strongly Influences Vector InfectivityHuman Gene Therapy, 1996
- Potential for H-DNA in the Human Mucin Gene PromoterPublished by Elsevier ,1996
- Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1Journal of General Virology, 1995
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal Of Cancer, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993